News Focus
News Focus
Followers 17
Posts 2328
Boards Moderated 0
Alias Born 10/26/2017

Re: None

Sunday, 12/10/2017 12:52:01 PM

Sunday, December 10, 2017 12:52:01 PM

Post# of 8130
Observations from last week stock price action:

The Bull Run still very strong. The trend ended last Friday with two continuous days of 20+% increases on very high volume.
My Forward P/S valuation analysis gives room for further SP increase since I am estimating a 17 to 19 conservative top for this stock. AND my valuations are fully diluted.
Last time I checked the 50 days Moving Average was @ 44 cents. Demonstrating a bullish trend.
The Nevada Cannabis Market is estimated to grow at a 54% CAGR for the next three years. Cannabis retail is very good right now.
The last 52wk high price was 56 cents on Feb 22 on 4.4M shares. The current trend seems stronger with actual operational developments.
There are over $4M (Cash) in the coffers (Like never before). Assuming the promissory notes are all gone by now.
Rapidly increasing revenue and good cash flow coming from the CuraCann Deal secures further financial stability.
There are 48M (60 & 65 cents) warrants. That’s a lot of future cash available without the need of further dilution.
This past week HAS CHANGED the overall financial position of the company. The financial risk has decreased enormously.
The cultivation operations has been a bit slow BUT very efficient. The first crops set the pace for future ones so it is OK to take it slow at the beginning.
Lets not forget the Medical Business Proposition. GB’s actual core business. The patents pending, The LSU & Univ. de Sevilla partnerships.
And last but not least the propagation (know how) technics which took three years to develop.

My new price target before christmas is $0.67 +/- 2 cents.